← Leaderboards
Kevin B. Freeman
University Of Mississippi Med Ctr
$6,825,230
Attributed
$10,448,577
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.3M · FY2012–25$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,448,577 · 5
By mechanism
R01$5,445,046 · 2
UG3$4,710,576 · 1
R41$180,830 · 1
R03$112,125 · 1
Top collaborators
- Sandra D. Comer1 shared
- Mahmoud A Elsohly1 shared
- Lawrence C Kuo1 shared
- Scott A. Reines1 shared
Most similar at University Of Mississippi Med Ctr
Same institution · by research overlap
- Daniela Rãedi-Bettschen$2,168,507
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDoseSelf AdministrationOpioidAnalgesicsProceduresAgonistPain ManagementBehaviorLaboratoriesOxycodoneReinforcement SchedulePrescription Opioid AbusePrescription OpioidAbsence Of Pain SensationSedation ProcedureMu Opioid ReceptorsPublic HealthDrug CombinationsReportingAdverse EffectsFormulationExhibitsMacaca Mulatta
Grant awards (15)
MEB-1170: A New Chemical Entity for the Treatment of Opioid Use Disorder$4,710,576
UG3 · FY2025 · DA
Deterrents for prescription opioid abuse$546,185
R01 · FY2025 · DA · contact PI
Deterrents for prescription opioid abuse$547,213
R01 · FY2024 · DA · contact PI
Deterrents for prescription opioid abuse$548,214
R01 · FY2023 · DA · contact PI
Deterrents for prescription opioid abuse$549,185
R01 · FY2022 · DA · contact PI
Deterrents for prescription opioid abuse$663,080
R01 · FY2021 · DA · contact PI
Deterrents for prescription opioid abuse$385,246
R01 · FY2019 · DA · contact PI
Deterrents for prescription opioid abuse$385,246
R01 · FY2018 · DA · contact PI
An Opioid/Cannabinoid Analgesic that Boosts Pain Relief and Blocks Opiate Reward$180,830
R41 · FY2018 · DA
Deterrents for prescription opioid abuse$385,246
R01 · FY2017 · DA · contact PI
Deterrents for prescription opioid abuse$407,344
R01 · FY2016 · DA · contact PI
Deterrents for prescription opioid abuse$459,628
R01 · FY2015 · DA · contact PI
Delay Discounting and the Choice to Take a Drug$290,030
R01 · FY2014 · DA · contact PI
Delay Discounting and the Choice to Take a Drug$278,429
R01 · FY2013 · DA · contact PI
Fat, sweet taste, and cocaine reinforcement in obese and lean Zucker rats$112,125
R03 · FY2012 · DA · contact PI